Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
NSAID use is associated with lower dementia and Alzheimer's disease prevalence and slower cognitive decline: A retrospective longitudinal analysis of the NACC cohort.
Journal: medRxiv : the preprint server for health sciences
Published: July 10, 2026
Leptin as a Potential Modifier of Neuroinflammation: Contrasting Roles in Alzheimer's Disease and Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: October 30, 2025
A preliminary study on plasma markers across cognitive stages and links to a history of mild traumatic brain injury.
Journal: Journal of Alzheimer's disease : JAD
Published: March 21, 2025
Plasma glial fibrillary acidic protein as a biomarker of acute focal brain injury after high-intensity focused ultrasound thalamotomy.
Journal: Brain communications
Published: September 10, 2024
Blood Markers in Relation to a History of Traumatic Brain Injury Across Stages of Cognitive Impairment in a Diverse Cohort.
Journal: Journal of Alzheimer's disease : JAD
Published: December 25, 2023
DnaJC7 specifically regulates tau seeding.
Journal: bioRxiv : the preprint server for biology
Published: March 30, 2023
Microglia as a cellular target of diclofenac therapy in Alzheimer's disease.
Journal: Therapeutic advances in neurological disorders
Published: September 06, 2022
Cognitive Decline in Older People with Multiple Sclerosis-A Narrative Review of the Literature.
Journal: Geriatrics (Basel, Switzerland)
Published: April 15, 2022
Anatomic survey of seeding in Alzheimer's disease brains reveals unexpected patterns.
Journal: Acta neuropathologica communications
Published: September 03, 2021
A synthetic heparinoid blocks Tau aggregate cell uptake and amplification.
Journal: The Journal of biological chemistry
Published: July 28, 2019
Last Updated: 09/26/2026